December 20, 2022 C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for all
December 20, 2022 C-Path Receives Letter of Support from EMA for Parkinson’s Disease Clinical Trial Simulation Platform TUCSON, Ariz., Dec. 20, 2022 — Critical Path Institute (C-Path) today announced that the European Medicines Agency (EMA) has iss
December 16, 2022 Quantitative Study Findings: Comparability of a Provisioned Device Versus Bring Your Own Device…
December 16, 2022 eCOA Consortium and PRO Consortium Announce Publication of Two Open Access Articles C-Path’s eCOA Consortium and PRO Consortium are pleased to announce the publication of two open access articles in the Jour
December 16, 2022 Qualitative Interview Findings: Comparability of a Provisioned Device Versus Bring Your Own Device…
December 14, 2022 View Now | Shared Stewardship in Collaborative Curation of Rare Disease Datasets Patient data is a key asset in understanding the progression of rare diseases and may it be provided in a variety of forms from a
December 11, 2022-December 14, 2022 15th Annual Conference on the Science of Dissemination and Implementation in Health Dec 11-14, Academy Health, Washington, DC Summary: Through a combination of plenaries, workshops, breakout, and poster sessions, t
December 8, 2022 ‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases AMSTERDAM, Netherlands, December 8, 2022 — A new initiative to boost research and development into rare and paediatric diseases
December 6, 2022-December 8, 2022 The Future of Health Summit Partnering for Patients, a Forum of the Future of Health Summit Washington, DC. December 6-8, 2022 “Creating New Markets for App